Skip to content

Clinical trials

Phase 3 Hyperphosphatemia trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Phase: Phase 3 Country / region: Japan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20092
20103
20111
20121
20134
20214

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc5
Bayer4
Kissei Pharmaceutical Co., Ltd.4
Kyowa Kirin Co., Ltd.4
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia18
Renal Insufficiency5
Renal Insufficiency, Chronic5
Kidney Failure, Chronic2
Chronic Kidney Disease-Mineral and Bone Disorder1
Vascular Calcification1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.